HCA Healthcare (NYSE:HCA) Rating Lowered to Market Perform at Raymond James

HCA Healthcare (NYSE:HCA) was downgraded by equities research analysts at Raymond James from an “outperform” rating to a “market perform” rating in a research report issued on Friday, MarketBeat.com reports.

Several other equities analysts have also issued reports on the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Wells Fargo & Company boosted their price objective on HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a research report on Wednesday, November 6th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Royal Bank of Canada boosted their price objective on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Finally, KeyCorp reduced their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Six equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $385.00.

HCA Healthcare Trading Down 2.2 %

Shares of HCA opened at $324.93 on Friday. HCA Healthcare has a 52-week low of $245.84 and a 52-week high of $417.14. The business’s fifty day moving average is $379.40 and its 200-day moving average is $358.35. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm has a market cap of $82.30 billion, a price-to-earnings ratio of 14.59, a PEG ratio of 1.28 and a beta of 1.68.

Insider Buying and Selling

In related news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is owned by company insiders.

Institutional Trading of HCA Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of HCA. Acadian Asset Management LLC increased its position in shares of HCA Healthcare by 115.5% during the first quarter. Acadian Asset Management LLC now owns 3,372 shares of the company’s stock valued at $1,123,000 after acquiring an additional 1,807 shares during the last quarter. CreativeOne Wealth LLC bought a new position in HCA Healthcare during the first quarter valued at $231,000. Advisors Asset Management Inc. grew its holdings in HCA Healthcare by 117.5% during the first quarter. Advisors Asset Management Inc. now owns 2,543 shares of the company’s stock valued at $848,000 after purchasing an additional 1,374 shares during the period. 1832 Asset Management L.P. bought a new position in HCA Healthcare during the first quarter valued at $26,672,000. Finally, LRI Investments LLC bought a new position in HCA Healthcare during the first quarter valued at $69,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.